The enrichment of HBV immune-escape mutations during nucleoside/nucleotide analogue therapy

Shan, ML; Shen, Z; Sun, H; Zheng, JH; Zhang, M

Zhang, M (reprint author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Lab Med, Shanghai, Peoples R China.

ANTIVIRAL THERAPY, 2017; 22 (8): 717

Abstract

Background: Drug-resistant HBV mutants frequently arise during nucleoside/nucleotide analogue (NA) therapy, while the resistance mutations on polymera......

Full Text Link